A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma

Author:

Araki Yoshihiro1,Asano Naofumi2,Yamamoto Norio1,Hayashi Katsuhiro1,Takeuchi Akihiko1,Miwa Shinji1,Igarashi Kentaro1,Higuchi Takashi1,Abe Kensaku1,Taniguchi Yuta1,Yonezawa Hirotaka1,Morinaga Sei1,Asano Yohei1,Yoshida Takeshi3,Hanayama Rikinari3,Matsuzaki Juntaro4,Ochiya Takahiro5,Kawai Akira6,Tsuchiya Hiroyuki1

Affiliation:

1. Department of Orthopedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa 920‑8641, Japan

2. Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo 160‑8582, Japan

3. WPI Nano Life Science Institute (NanoLSI), Kanazawa University, Kanazawa, Ishikawa 920‑1192, Japan

4. Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo 105‑8512, Japan

5. Department of Molecular and Cellular Medicine, Tokyo Medical University, Tokyo 160‑0023, Japan

6. Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo 104‑0045, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3